Cresco Labs (CRLBF) Profit After Tax (2020 - 2026)
Cresco Labs (CRLBF) posted Profit After Tax of -$17.0 million for Q1 2026, up 80.87% on a QoQ basis from -$88.9 million in Q4 2025, and down 11.68% year-over-year from -$19.3 million in Q1 2025.
Cresco Labs (CRLBF) Profit After Tax (2020 - 2026) Analysis & Trends
Cresco Labs' Profit After Tax history runs 7 years deep, the most recent figure standing at -$17.0 million for Q1 2026.
- Quarterly Profit After Tax fell 11.68% year-over-year to -$17.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$141.8 million (down 92.52% YoY) and the FY2025 annual result came in at -$134.8 million, down 81.1% from the prior year.
- Profit After Tax was -$17.0 million for Q1 2026 at Cresco Labs, up from -$88.9 million in the prior quarter.
- Across five years, Profit After Tax topped out at $23.7 million in Q1 2022 and bottomed at -$180.6 million in Q4 2022.
- A 5-year average of -$32.3 million and a median of -$15.2 million in 2025 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax surged 375.29% — and 2025, when it slumped 20361.73%.
- Cresco Labs' Profit After Tax stood at -$180.6 million in 2022, then jumped by 102.7% to $4.9 million in 2023, then plunged by 90.98% to $439000.0 in 2024, then slumped by 20361.73% to -$88.9 million in 2025, then soared by 80.87% to -$17.0 million in 2026.
- Business Quant data shows CRLBF's Profit After Tax at -$17.0 million in Q1 2026, -$88.9 million in Q4 2025, and -$22.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 32.69 Bn | 30.75 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.61 Bn | 23.55 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.53 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Cresco Labs | 240.79 Mn | 177.22 Mn | 75.45 Mn | -17.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.01 Mn |
| Dec 31, 2025 | -88.95 Mn |
| Sep 30, 2025 | -21.97 Mn |
| Jun 30, 2025 | -13.89 Mn |
| Mar 31, 2025 | -15.23 Mn |
| Dec 31, 2024 | 439,000.00 |
| Sep 30, 2024 | -7.69 Mn |
| Jun 30, 2024 | -51.18 Mn |
| Mar 31, 2024 | -2.06 Mn |
| Dec 31, 2023 | 4.87 Mn |
| Sep 30, 2023 | -113.45 Mn |
| Jun 30, 2023 | -43.46 Mn |
| Mar 31, 2023 | -27.81 Mn |
| Dec 31, 2022 | -180.62 Mn |
| Sep 30, 2022 | -3.25 Mn |
| Jun 30, 2022 | 8.30 Mn |
| Mar 31, 2022 | 23.68 Mn |
| Dec 31, 2021 | 11.91 Mn |
| Sep 30, 2021 | -263.45 Mn |
| Jun 30, 2021 | 2.65 Mn |